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Abstract

Author Manuscript

Objective: A lack of understanding of the causes of attrition in longitudinal studies of older
adults may lead to higher attrition rates and bias longitudinal study results. In longitudinal
epidemiological studies of Alzheimer’s disease and related dementias, high rates of attrition may
cause a systematic underestimation of dementia prevalence and skew the characterization of the
disease. This can compromise the generalizability of the study results and any inferences based on
the surviving sample may grossly misrepresent the importance of the risk factors for dementia.
The National Institute on Aging outlined a National Strategy for Recruitment and Participation in
Alzheimer’s Disease Clinical Research to address this problem, providing evidence of the
magnitude of this problem.
Method: To explore predictors of attrition, this study examined the National Alzheimer’s
Coordinating Center (NACC) Uniform Data Set; a repository of observations of older adults
spanning 11 years, using survival analysis. Four samples were examined: the full sample
(n=30,433), the alive subsample excluding those who died (n=24,231), the MRI sample
(participants with complete MRI data (n=1,104)), and the alive MRI subsample (participants with
MRI data excluding those who died (n=947)).
Results: Worsening cognitive impairment, neuropsychiatric symptoms, and difficulty with
functional activities predicted attrition, as did lower hippocampal volume in the MRI subsample.
Questionable co-participant reliability and an informant other than a spouse also increased risk of
attrition.

Author Manuscript

Discussion: Special considerations exist in recruiting and retaining older adults in longitudinal
studies and results of baseline psychological, functional, and cognitive functioning should be used
to identify targeted retention strategies.
Keywords
Alzheimer’s disease; attrition; dementia; drop-out; longitudinal study; neuropsychiatric symptoms;
hippocampal volume; functional difficulties

Introduction

Author Manuscript

Attrition is one of the main challenges in longitudinal studies. It refers to the drop out of
participants during the course of a study, including drop outs between data collection points
or study waves and before the completion of a study [1, 2]. Study participants may miss one
wave of a study and return at a later point or may miss one testing point and never return [3].
The latter, which is called terminal attrition, is more common and is the topic of attrition in
this paper. Attrition is usually non-random and can threaten the internal and external validity
of a study [2, 4, 5]. If attrition creates a difference in group composition and associations
between variables of a sample, it poses a threat to internal validity [1]. If attrition causes a
change in characteristics of participants in the original sample compared to the subsequent
waves, it poses a threat to external validity [1, 2, 6]. These threats to validity are called
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attrition bias and can change the findings in a study [1]. Therefore, it is important to
understand the causes of attrition, especially those that may be preventable, in order to
increase the validity and generalizability of empirical studies in different groups.

Author Manuscript

Attrition could occur due to an array of reasons including refusal for participation, lack of
interest, premature withdrawal, failed contact, incompatibility with the research team, or
incapability of participation due to illness, injury, or death [2, 4, 7]. Attrition could be
higher, and a cause of concern, in studies on specific groups such as the population under
investigation in this study, older adults. In longitudinal studies on older adults, high attrition
rates due to death is a cause of concern and can create a challenge in exploring the aging
process in later stages of life [8–10]. For instance, 38% attrition was reported due to death or
mental or physical incapacitation in Feng et al.’s [9] longitudinal study (between 1970-2005)
among older adults (mean age at baseline= 64.07, SD= 5.65); close to 22% attrition due to
death was reported in the second wave (between 3.3 to 4.2 years after the baseline) and
around 26% in the third wave (between 3.7 to 4.4 years after the second wave) of Jacomb et
al.’s [10] study among older adults (aged 70 or older at the baseline); and around 20%
attrition due to death among older adults (mean age at baseline= 77.9, SD= 6.8) was
reported in a 2-year study by Coley et al. [11].

Author Manuscript

Sociodemographic characteristics of the participants may also influence attrition in
longitudinal studies, specifically on older adults. For instance, in the Maastricht Aging Study
among adults aged 49 and older at baseline, those who were lost in the three-year follow-up
were more often females, had poorer results on neurocognitive tests at baseline, and had
lower levels of educational attainment [12]. Similarly, in the study by Jacomb et al. [10] on
predictors of older adults’ refusal to participate in a longitudinal study, non-participants were
found to have lower years of education and lower cognitive performance scores. Besides
gender and education, race and age of older adults are among the socio-demographic
characteristics found to be associated with attrition rates in longitudinal studies [13–16].

Author Manuscript

The literature also supports an association between mental and physical health of older adult
participants, specifically adults living with cognitive impairment and dementia, and attrition
in longitudinal studies. For example, in Coley et al.’s [11] study on older adults living with
mild to moderate Alzheimer disease, institutionalization, loss of autonomy, and increasing
caregiver burden were among the major reasons unrelated to mortality that led to sample
exit. Similarly, in Tyas et al.’s [17] study on a sample of aging and dementia population,
attrition was associated with institutionalization. Moreover, Sliwinski et al. [18] found an
association between time to drop out and accelerating memory loss among a sample of older
adults. In line with these findings, loss of autonomy, institutionalization, illness, lower level
of functioning ability, increased cognitive impairment or low cognitive status, and brain MRI
findings indicating higher future risk of dementia (white matter lesion volume and
hippocampal volume) are also found to be associated with attrition in longitudinal studies
among older adults [11, 13, 15, 19–21].
Additionally, our review of the literature found inconsistent results in previous studies
regarding an association between neuropsychiatric symptoms among older adults living with
dementia and attrition in longitudinal studies. Steinberg et al [22] found a correlation
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between neuropsychiatric symptoms such as delusions, hallucinations, agitation/aggression,
anxiety, disinhibition, and irritability among a cohort of older adults living with dementia
and attrition. Another study among a similar population found neuropsychiatric symptoms
of patients who fulfilled total follow-up were similar compared to those individuals who had
died or were discontinued from the study [23]. We also retrieved studies suggesting a
correlation between attrition and the relationship of the caregiver and older adults. In these
studies, drop out was higher among older adult patients cared for by caregiver not related to
the patient [11, 19].

Author Manuscript

A lack of understanding regarding what causes participants to drop out will lead to higher
attrition rates, and this can bias the overall results of a study. In large-scale longitudinal
epidemiological studies of dementia, high rates of attrition may cause a systematic
underestimation of dementia prevalence. This underestimation can compromise the
generalizability of the study results. Therefore, any inferences made on the surviving sample
may grossly misrepresent the importance of the risk factors for dementia, which may have
been identified. In the current study, we aim to expand on the previous studies in the field to
better understand potential causes of attrition and magnitude of this problem in longitudinal
studies, specifically epidemiological studies of Alzheimer’s disease among older adults. In
this context, we utilized the National Alzheimer’s Coordinating Center’s Uniform Data Set
to explore three hypotheses informed by the findings of our literature review.

Author Manuscript
Author Manuscript

We hypothesized that attrition in our sample is associated with the sociodemographic
characteristics of the participants including their sex, age, education, and race. Moreover, we
hypothesized that attrition in the sample is correlated with mental health of the participants,
specifically their neurological and behavioral status based on: the Clinical Dementia Rating
(CDR) global score (0, 0.5, 1, 2, and 3); cognitive status (impaired but not diagnosed with
mild cognitive impairment [MCI], diagnosed with MCI, and diagnosed with dementia);
depression based on the Geriatric Depression Scale (GDS); and finally, neuropsychiatric
symptoms (NPSs, delusion, hallucination, agitation, depression, anxiety, elation, apathy,
disinhibition, irritability, motor disturbance, nighttime disturbance, and appetite disturbance)
based on the Neuropsychiatric Inventory Questionnaire (NPI-Q). Furthermore, we
hypothesized that attrition in the sample is correlated with the physical health of the
participants, including functional activity status based on the Functional Assessment
Questionnaire (FAQ) or Functional Assessment Scale (FAS) (0-10: normal ability, 11-20:
needs assistance, 20-30: dependent) and white matter and hippocampal volumes based on
the MRI results. Additionally, we hypothesized that attrition in the sample is associated with
co-participant relation (spouse, child, sibling, other relative, friend or someone known, paid
caregiver, and others) and reliability defined based on the clinician’s judgment. In order to
examine these hypotheses, we used survival analysis [24]. For this analysis, we created
subsamples excluding participants who died during data collection, as we expected a major
attrition due to death in the utilized dataset based on the reviewed literature.
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Method
Data
Data of this study was obtained from the National Alzheimer’s Coordinating Center’s
(NACC) Uniform Data Set (UDS), representing the years 2005 to 2016. Four samples were
studied based on the obtained data from the NACC UDS: 1) full sample (n=30,433), 2) the
alive subsample: a subsample based on the full sample excluding participants who died
during the course of the study (n=24,231), 3) the MRI sample: a sample consisted of
participants who had MRI information (n=1,104), and 4) the alive MRI subsample: a
subsample consisted of participants who had MRI information, excluding those who died
(n=947). The specific MRI data of interest in this study were white matter hyperintensities
and hippocampal volume [25].

Author Manuscript

Information in the NACC UDS data set is obtained from 35 Alzheimer’s Disease Centers
(ADCs) at a baseline visit and subsequent annual evaluations. At each visit, the data was
obtained from the participant, a trusted co-participant (also known as an informant),
qualified clinicians (psychometricians, neuropsychologists, neurologists, psychiatrists,
internists, and radiologists) and from laboratories, which provide results from blood,
cerebrospinal fluid (CSF), and autopsied brain samples. Each participant and their coparticipant provided a variety of demographic and social history data, as well as medical
history and use of medications in the NACC UDS dataset.
Measures

Author Manuscript

Death.—Mortality was included as a categorical variable, in which 1 indicated a person had
died, and 0 indicated that they are still alive. Based on the death in the sample, we generated
two subsamples to review attrition factors unrelated to mortality. Excluding the deaths from
the full sample, we generated the alive subsample. Moreover, excluding the deaths from the
MRI sample (consisted of participants who had MRI information), we created the alive MRI
subsample.
Sociodemographic characteristics.—To test our first hypothesis, we measured the
associations between attrition and socio-demographic characteristics of the participants.
These characteristics include sex, age, number of years of education, and race. Age and
number of years of education (continuous from 0-36 years, where 12 years = high school /
GED, 16 = Bachelor’s degree, 18 = master’s degree, 20 = doctorate) were continuous
variables, and sex and race (white non-Hispanic [reference group], black non-Hispanic,
Hispanic, other) were categorical.

Author Manuscript

Mental and physical health.—To test our second hypothesis, we measured the
associations between attrition and physical and mental health of the participants in our
sample. Participants were assessed using a variety of rating scales for mental and physical
health, including the Clinical Dementia Rating scale [26], an adapted version of the
Functional Activities Questionnaire [27], and the Neuropsychiatric Inventory Questionnaire
[28]. Radiologists and pathologists at some ADCs voluntarily provide data from MRIs, and
amyloid PET scans, which NACC stores in a repository. At the discretion of the individual
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ADCs, laboratory and imaging tests are obtained from participants to aid in diagnostic
determinations and provide information about medical illnesses when completing UDS
forms. Clinicians obtain data from psychometric, medical, neurological, and psychiatric
evaluations as well as diagnostic information. A diagnosis regarding cognitive status is often
determined by a group of two or more clinicians, neuropsychologists, or the examining
physician [25].

Author Manuscript

The first mental health-related predictor for attrition in this study was the CDR global score.
The CDR takes into account six domains, which are scored individually based on the coparticipant report and neurological and behavioral exam of the participants. The six domains
include memory, orientation, judgment and problem-solving, community affairs, home and
hobbies, and personal care [26, 29]. Each domain is rated based on the participant’s
cognitive (not physical) ability to function in these areas. Once an individual score is derived
in each domain, an algorithm can be used to compute the global score [29]. The overall
score of the CDR pertains to a certain cognitive status such that 0 = normal, 0.5 = very mild
dementia, 1 = mild dementia, 2 = moderate dementia, and 3 = severe dementia. Therefore,
this predictor in this study was a categorical variable with four categories (CDR global score
equal to 0 [reference group], 0.5, 1, 2, and 3).
The second mental health-related predictor for attrition in this study was cognitive status.
Physicians and neuropsychologists at individual ADCs diagnosed the cognitive status of the
participants based on the guidelines set forth by McKhann et al. [30] through a consensus
diagnosis process, or by a single clinician. Cognitive status in this study was a categorical
variable with four categories: normal cognition (reference group) impaired but not diagnosed
with MCI, diagnosed with MCI, and diagnosed with dementia.

Author Manuscript

Depression was the third mental health-related predictor for attrition in this study. This
predictor was based on the total score of the short version of the GDS[31]. The short version
of the GDS is a 15-item self-report questionnaire with yes or no answers. Answering yes to
10 of the questions in the short version of the GDS indicates the presence of depression
while answering no to the other five is indicative of depression. Therefore, depression in this
study was a categorical variable separating depressed adults from others (reference group).

Author Manuscript

Moreover, in this study, we reviewed the participants’ NPSs as the fourth mental healthrelated predictor for attrition. In the utilized dataset for this study, NPSs were assessed using
the NPI-Q [28]. This questionnaire assesses presence or absence of a problematic behavior
in 12 categories based on an interview with co-participants: delusion, hallucination,
agitation, depression, anxiety, elation, apathy, disinhibition, irritability, motor disturbance,
nighttime disturbance, and appetite disturbance.
Functional activity status of older adults was a physical health-related predictor for attrition.
This predictor was defined based on the FAQ or FAS measures. The FAQ was designed
based on the Functional Activities Questionnaire [27], which later was adapted to FAS in the
UDS version 3. The FAS is a 10-item tool assessing difficulty or a need for help in
conducting daily activities based on the co-participant report. The 10 items of the
questionnaire include paying bills; assembling records and business affairs; shopping alone
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for home goods or clothes; playing a game of skill or working on hobbies; heating water or
making coffee; preparing a balanced meal; tracking current events; following and
understanding a TV program, magazine or book; and traveling, driving, or taking public
transportation. Each item could be scored from 0 to 3. Score 3 indicates that the individual is
completely dependent on someone else for that task; 2 shows that the person has difficulty in
conducting the task but can do it by him or herself; 1 indicates that the individual needs
assistance; and 0 shows normal ability. In this study, functional activity is a categorical
variable based on the total score of the FAS (0-10: normal ability [reference group]; 11-20:
needs assistance; 20-30: dependent). Furthermore, we reviewed the participants’ MRI
results, specifically their white matter and hippocampal volumes as another physical healthrelated predictor for attrition in this study. Both of these predictors were continuous
variables.

Author Manuscript

Co-participant relation and reliability.—We also included information regarding the
co-participant’s relationship to the participant as a predictor for attrition, given that a coparticipant is required to participate in NACC studies. The assumption was that the coparticipant would provide reminders for appointments, travel assistance, and potentially
motivation to attend. The co-participant as a predictor in this study was a categorical variable
and included the spouse (reference group); child; sibling; other relative; friend, neighbor, or
some known through family, friends, work or community; paid caregiver, health care
provider, or clinician; and others. Moreover, the reliability of the co-participant was included
in this study as a predictor for attrition, and this categorical variable was based on the
clinician’s judgment.
Data Analysis

Author Manuscript
Author Manuscript

In the analyses, a failure event was defined as a participant’s exit from the study. An exit was
defined as the participant’s last visit occurring at least three years before the last survey
observation in 2016. The rationale for constraining the analytic sample in this fashion first
started as a calculation of the intervals between any two consecutive visits for the same
person. We estimated (calculated) that for 99% of people, the likelihood of their return visit
following their last visit was less than one percent, especially if someone did not attend a
study visit or observation for three years. While the participants had the opportunity for
additional visits, the fact that they did not return for a follow-up visit means their exit was
the result of circumstances unrelated to lack of additional opportunities for follow-up
observations (such as a study ending) or death. Right censoring was used to account for
participants whose last visit occurred during the last three years of collected information, as
their visits or attrition may occur in future visits but are unaccounted for at the present. Time
zero was equal to the participant’s first observation (visit number 1), and time was measured
in visits. There was a range of 1 to 10 visits for all counted participants. Outcomes are
displayed as hazard ratios. The statistical program STATA [32] was utilized for the analyses,
and a p-value < 0.05 was considered statistically significant.
Univariate analysis was conducted to determine frequencies and distributions of values
within all variables across each sample and subsample including male sex, age, education,
race, CDR scores, cognitive status, depression, NPSs, FAQ or FAS score, MRI indicator
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including white matter and hippocampal volumes, relationship with informant, and
reliability of informant. Baseline survival function was determined using log-rank tests for
categorical variables and examined through inspection of Kaplan-Meier plots (see Figures 1
and 2 for Kaplan-Meier plots of the full sample and the MRI sample). Visual inspection of
Kaplan–Meier plots were consistent with log-rank tests. Only variables which demonstrated
significantly different survival curves among participants were used in the Cox survival
analyses. The relationship of selected continuous variables was examined relative to the
outcome variable using the Cox proportional hazards model [33]. Cox survival analyses
were performed for exploration of the effects of the main variables on attrition in the full
sample, alive subsample, MRI sample, and alive MRI subsample. Covariates, which were
found to be statistically significant in Table 2, were used to predict the hazard ratio of a
failure event (exit from the survey). Regression modeling included simultaneous control of
multiple predictors, including male sex, age, education, race, CDR global score, cognitive
status, depression, incidence of NPSs, FAQ/FAS score, white matter hyperintensities,
hippocampal volume, relationship with co-participant, and reliability of co-participant was
conducted. An additional subsample analysis was conducted on the alive subsample, which
excluded participants who died (n= 24,231), the MRI sample: a group of participants who
also had complete UDS and MRI data (n=1,104), and the alive MRI subsample (n=974). For
the analysis with the MRI sample and alive MRI subsample, MRI indicators, such as white
matter hyperintensity and hippocampal volume, were also included.

Author Manuscript
Author Manuscript

Individual ADCs not only employ their own individual recruitment protocols but also use a
variety of means to obtain follow-up observations from participants. In 2002, the ADC
Clinical Task Force was established by the National Institute on Aging to standardize the
data collection procedures and participant evaluations across each of the ADCs. In doing so,
they also created an annual schedule of follow-up [34], though the methods to encourage
follow-up remain individualized to each ADC. The differing recruitment methods and study
protocols at each ADC were adjusted as a center specific fixed effect (only 3 centers had
complete MRI information, so we adjust for 3 fixed effects with this subsample). Huber–
White-corrected standard errors are used to adjust for clustering at the center level.

Results
Participants in the Full Sample

Author Manuscript

The minimum number of visits for all included participants was 1 and the maximum was 11
(mean = 3; median=3.26). There were 20,256 exits (failures) by the end of the observation
period among NACC participants with complete information on variables we used for the
analysis. Among all exits, 10,640 participants dropped out after the first visit, and 6,202
participants exited the survey due to the event of death. For the full sample, there were 5,577
failures among individuals with normal cognition, 819 failures among individuals deemed
impaired not MCI, 4,319 failures for those with MCI, and 9541 failures for those with
dementia. Among the 1,174 individuals with complete MRI information, there were 431
total failures, 152 of which were among those with normal cognition at baseline, 30 among
those deemed impaired not MCI, 143 with MCI, and 106 failures for those with dementia.
For the full sample, around 44% of the sample was male, the mean age of participants at
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visit one was 72.60 years (SD: 10.38), and the mean years of education was 14.91
(SD=3.52). The majority of the full sample was White (around 76%), around 14% were
Black non-Hispanic, seven percent of the sample reported Hispanic origin, and around three
percent were from other ethnic groups. Almost 37% of the sample had a normal CDR score,
and near 36% of participants were diagnosed with normal cognition. Around four percent of
the sample were diagnosed with impaired cognition but not MCI, around 21% with MCI,
and around 38% with dementia. Close to 19% of the sample had depression based on the
GDS, and three percent to 29% had at least one neuropsychiatric symptom. Over 71% of
participants were determined to have a FAQ or FAS score lower than 10, indicating few
difficulties with functional performance, while about 15% of participants had a score
between 11-20, signifying a need for some level of assistance in conducting daily activities.
Moreover, around 13% of the full sample had a FAQ or FAS score between 21 and 30, which
indicates a high level of dependence in conducting daily activities. In the full sample, over
56% of co-participants were the spouses of the participants, over 24% were their children,
and the remaining co-participants were comprised of siblings, friends, caregivers, or had
other relations with the participants (see Table 1).
Participants in the Alive Subsample

Author Manuscript

Participants in the alive subsample (attrition for reasons other than death) were significantly
different from participants in the full sample in relation to demographic variables and mental
and physical health (see p-values reported in Table 1). Participants in this subsample were
slightly more likely to be female, younger, and more educated. They were also more likely
to be Black non-Hispanic or Hispanic compared to the participants of the full sample.
Participants in the alive subsample were more likely to have a lower CDR score
(demonstrating normal neurological and behavioral status), and normal cognition compared
to the participants of the full sample. Moreover, participants in this subsample were slightly
less likely to have depression and any of the 12 denoted neuropsychiatric symptoms in the
NIQ. Additionally, participants in this subsample were more likely to have a FAQ or FAS
score between 11-20 indicating a lower level of dependence in daily activities. Coparticipants in this subsample were slightly less likely to be the spouses or partner or
children of the participants and slightly more likely to be paid caregivers compared to the
full sample (see Table 1).
Participants in the MRI Sample

Author Manuscript

Participants in the MRI sample were more likely to be female and less likely to be White
non-Hispanic compared to the participants of the full sample and alive subsample. The
average age of the participants in the MRI sample was slightly lower than the full sample
and higher than the alive subsample. Moreover, the average years of education of the
participants in this subsample was slightly lower than the full sample and the alive
subsample. Participants in this subsample were more likely to have normal neurological and
behavioral status based on the CDR, and normal cognition based on the diagnosis of the
clinicians compared to the full sample and the alive subsample. Moreover, participants in the
MRI sample were less likely to have depression and all 12 neuropsychiatric symptoms
indicated in the NIQ. They also had better functional ability in daily activities compared to
the participants in the full sample and the alive subsample. Co-participants in this subsample
Aging Clin Exp Res. Author manuscript; available in PMC 2020 September 01.

Burke et al.

Page 10

Author Manuscript

were slightly more likely to be the spouses or partners of the participants and less likely to
be paid caregivers (see Table 1).
Participants in the Alive MRI Subsample

Author Manuscript

Compared to those in the MRI sample, participants in the alive MRI subsample were more
likely to be female, had a lower average mean age at the baseline, had higher average years
of education and were more likely to be White non-Hispanic. Participants in this subsample
were more likely to have normal neurological and behavioral status, and normal cognition
compared to the MRI sample. Moreover, participants in this subsample were less likely to be
depressed or have any neuropsychiatric symptoms based on the NPI-Q compared to the
participants in the MRI sample. Participants in the alive MRI subsample were more likely to
have lower scores in FAQ or FAS, indicating higher levels of independence in daily activities
compared to the participants of the MRI sample. Participants in this subsample had lower
white matter hyperintensities (6.90 vs 8.28, p <0.001) and higher hippocampal volume (6.21
vs 6.12, p <0.001) compared to those in the MRI sample. Co-participants in this subsample
were more likely to be spouses or partners of the participants or paid caregivers compared to
the MRI sample. Percentages, means, and standard deviations (where applicable) for the full
sample and subsamples are displayed in Table 1.
Univariate and Multivariate Analyses

Author Manuscript

Preliminary univariate analysis using the log-rank test for equality of survivor functions in
the full samples revealed statistically significant differences (p < 0.001) in the survival
curves of those with different mortality statuses, age, years of education, participants who
were white non-Hispanic or Hispanic, all levels of CDR global scores, cognitive status,
depression, all NPs, all levels of FAQ or FAS scores, and relationships with co-participants,
specifically spouses, children, other relatives, and friends/neighbors. Results for the log-rank
tests are summarized in Table 2. Regression results are summarized in Table 3. For the full
sample and MRI sample (Columns 1 and 3, Table 3), the event of death increased the hazard
of exiting the study by about 2 times (Hazard Ratio (HR): 1.92, 95% CI: 1.67-2.19; OR:
2.54, 1.40-4.63; p<0.01, respectively). A higher educational level was associated with lower
attrition within the full sample (HR: 0.97, 0.97-0.98), alive subsample (HR: 0.97, 0.96-0.98),
MRI sample (HR: 0.97, 0.96-0.99), and the alive MRI subsample (HR: 0.95, 0.93-0.97).
Hispanic participants were less likely to exit the study in the full sample (HR: 0.85,
0.76-0.96), and alive subsample (HR: 0.85, 0.72-0.99), compared to White non-Hispanic
participants.

Author Manuscript

Worsening CDR score and cognitive status increased the hazard of exiting the study in the
full sample (CDR global score of 3 = HR: 1.67, 1.47-1.91) and the alive subsample (CDR
global score of 3 = HR: 1.44, 1.18-1.77)). A CDR global score of 3 was also significantly
associated with attrition in the MRI sample (HR: 2.29, 1.50-3.48) and the MRI alive
subsample (HR: 2.49, 1.23-5.06), p<.01), and a CDR global score of 2 was also associated
with attrition in all categories, except the MRI full sample. A number of NPSs also
influenced the stability of a person’s study participation. For instance, in the alive subsample
if participants had depression (HR: 1.07, 1.03-1.11), exhibited agitation (HR: 1.07,
1.02-1.11, or reported an appetite disturbance (OR: 1.09, 1.03-1.15), they were more likely
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to exit the study prematurely. In the alive MRI sub sample, a different pattern emerged in
which the presence of elation (HR: 1.37, 1.22-1.55, p < .01), disinhibition (HR: 1.65,
1.38-1.96), and an appetite disturbance (HR: 1.43, 1.11-1.84) predicted early attrition. The
presence of apathy also led to a higher risk of early attrition in the full sample (HR: 1.04,
1.00-1.08) and in the MRI sample (HR: 1.15, 1.09-1.22). Interesting, the presence of motor
disturbance (HR: 0.65, 0.61-0.68) and nighttime disturbance (HR: 0.78, 0.65-0.94) in the
alive MRI subsample was associated with a participant staying in the study.

Author Manuscript

Increased difficulty with daily activities measured by a higher FAQ score (between 21 and
30) also increased the hazard of leaving the study in the full sample (HR: 1.10, 1.02-1.19),
alive subsample (HR: 1.13, 1.01-1.25), and alive MRI subsample (HR: 1.10, 1.07-1.13). In
the MRI sample analyses, where we control for two MRI indicators, lower hippocampal
volume was associated with higher likelihood of exiting the survey (HR: 0.92, 0.89-0.94).
Moreover, when participants were accompanied by co-participants (informants) other than
their spouse, they experienced a statistically significant increased hazard of exiting the study
in the full sample (HR: 1.23, 1.08-1.39 for paid caregiver or health care provider) and the
alive subsample (HR: 1.26, 1.03-1.54 for paid caregiver or health care provider). The
reliability of the co-participants themselves was also significantly associated with early
attrition from the study among all participant samples.

Discussion

Author Manuscript

In this study, univariate analyses showed that attrition could be associated with mortality,
age, education, race, CDR score, cognitive status, FAQ or FAS score, and co-participant
relation. Moreover, our Cox survival analyses found that attrition could be associated with
mortality, education, race, CDR score, cognitive status, some of the NPSs, FAQ or FAS
score, and hippocampal volume. However, hazard ratios for attrition between the full sample
and the alive subsample were only slightly different, indicating the importance of other
associated factors of attritions besides death.

Author Manuscript

The study results support the existing literature, in which increasing age, NPSs, and
cognitive impairment are consistently related to greater rates of attrition [13, 22, 36, 37].
Moreover, an increase in the number of educational years in the full sample and subsamples
of this study found to be associated with a reduced likelihood of study drop-out (p < .01).
This is in line with previous studies [38, 39], though mixed results are found in the literature.
Reinwand et al. [40] most recently examined seven studies with the specific intent of
examining the effect of educational level on attrition rates. Their findings point to
significantly higher attrition among participants with no education, primary, or lower
vocational school attainment compared to those with professional or University education.
In these same studies, attrition was significantly higher among those with secondary
vocational school or high school education compared to participants with professional or
University education. However, there was a lack of association between attrition rates and
educational level in four out of seven studies reviewed by Reiwand et al [40]. Though the
current study demonstrated that higher educational attainment is associated with a reduced
likelihood of attrition, the peer-reviewed literature remains mixed and further studies in a
nationally representative sample are needed. In addition, specific information about
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educational type, quality, field/industry, and even occupation may provide further detail that
will elucidate why the literature is mixed and what the predictive educational factor may be
with regard to attrition.
In addition to education, the presence of depression significantly increased the hazard of
attrition in the full sample (HR: 1.04, 1.00-1.09). This finding is in line with the previous
literature in which depression was an independent predictor of attrition, and associated with
all other risk factors for attrition [38]. For instance, Beekman et al. [38] reported a 73.6%
response rate among those without depression symptoms, and a 63% rate among those with
depression (OR: 1.67; 1.36-2.06). In addition, depression, whether prodromal or an
independent lifelong risk factor, has been found to increase the hazard of cognitive
impairment [41–44], and increasing severity of cognitive impairment is associated with
attrition [7, 9, 12, 37].

Author Manuscript

Moreover, race and ethnicity of the participants was associated with attrition in this study.
Although the majority of participants were White, Black non-Hispanic participants were
more likely to attrite in both the full sample and the MRI sample. This phenomenon
persisted even when excluded participants who died during the course of the study.
Meanwhile, Hispanic participants, though less than five percent of the participants in the
NACC database, were less likely to attrite compared to white non-Hispanic participants. As
such, there are special considerations that researchers should heed when working with older
adults of minority backgrounds, though these suggestions can be tailored to the racial,
ethnic, and cultural background of the participants given that different groups are
experiencing more or less risk of attrition.

Author Manuscript

The finding, which revealed that reduced hippocampal volume was associated with risk for
drop out from the study, was a new finding given that only one previous study examined
hippocampal volume in relation to a lack of follow-up for imaging sessions. Though the
exact reason for this association requires further study, this finding is likely to be related to
the association of hippocampal atrophy to memory and cognitive decline [45–47]. This
phenomenon is supported by a previous study in which participants who had poorer results
on neurocognitive tests at baseline were more likely to attrite [12]. In this study, in addition
to reduced hippocampal volume, we also found a relationship between increased white
matter hyperintensities and the attrition rate. These findings are in line with a recent study
that evaluated brain MRI measures and study attrition. Glymour et al. [19] found that greater
baseline levels of white matter lesion volume increased the likelihood of attrition, and
greater declines in hippocampal volume between baseline and follow-up imaging sessions
were also related to study drop out.

Author Manuscript

Limitations
Some additional factors that may influence attrition were not available for examination in
the current dataset. For instance, among older adults, beliefs about the advantages of
participation in a study have been found to be associated with frequency of participation
[15]. Moreover, although this study identifies factors influencing attrition in a large
longitudinal database, we did not include the role of frailty or illness, which may require
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additional individual attention from investigators. Individuals with severe cognitive
impairment may not be able to answer researchers’ questions reliably, may be unable to
respond to researchers’ attempt at follow-up, and may not be able to keep appointments for
follow-up. Income, socioeconomic status, and geographic distance away from the observing
ADC, important sociodemographic variables that may influence a participant’s ability to
follow-up, were not available for analysis in the NACC data. Future studies conducted on the
NACC database should account for the variation in research designs across different
Alzheimer’s Disease Centers in the United States, including case series, case-control studies,
and even studies which may approximate a cohort study design. In addition, milestone data
submitted to NACC by individual ADCs specifies whether the participants are discontinued/
dropped from the study and whether they will be followed minimally until autopsy, and thus
are not actually discontinued from the study. Even when an autopsy is performed, the
information available to NACC may be subject to the time interval within which the
individual ADC provides the results. Therefore, using milestone data may result in a
different conclusion than applying the 3-year attrition cut point that was developed for the
purposes of this study. A particular strength of this study was the large sample size, number
of visits, and, even with the known limitations, the ability to validate and expand upon the
existing literature base.

Recommendations and Conclusion

Author Manuscript

Deeg et al. [7] have suggested that there are two different sources of attrition – unmodifiable
causes, outside the control of the researcher, and modifiable causes that can be changed by
the researcher. Mortality, advancing age, cognitive decline, increased NPSs, limitation in
physical ability, and variations in hippocampal volume are unmodifiable and inevitable
sources of attrition. Unmodifiable associated factors with attrition should be accounted for in
the design of the study. For instance, compensation could be made during recruitment to
maintain adequate statistical power after attrition related to these unmodifiable sources. In
this context, some researchers oversample individuals at greater risk of dropping out with
the hopes that adequate numbers are retained by study completion [13]. This study found
that attrition could be associated with modifiable causes such as considerations in working
with participants from different racial and ethnic groups and unmodifiable causes such as
death in a longitudinal study of older adults. The design of longitudinal studies could be
improved so as to minimize attrition by learning lessons from the findings of this and other
studies.

Author Manuscript

For attrition related to unmodifiable causes, strategies such as oversampling individuals at
greater risk of attrition and recruiting proxies could be considered. It has been found that
including information by proxy respondents, as opposed to excluding proxy information
during participant attrition, resulted in a 12% increase in estimated dementia prevalence
[49]. For attrition related to modifiable risk factors, targeted strategies may minimize
attrition. Andersen and Newman [51] developed a theoretical framework that seeks to
explain the effect of individual determinants on medical care usage, which we believe can be
applied to a discussion of attrition in health-related studies. In this context, education might
be thought of as a “predisposing variable” such that it influences a participant’s attitudes or
beliefs about their needs for services or observations. In contrast, depression not only signals
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a “need-for-care” but it also might be characterized as an enabling factor, which might
facilitate, or in this case, hinder the participants’ utilization of services. The importance of
these individual factors in study follow-up and completion signals the need for early
identification of these attrition risk factors in participants, and the development of
procedures to ensure their participation until the study ends.

Author Manuscript

Researchers can increase retention by (a) gathering sufficient tracking information at
baseline, and forging formal and informal working relationships with third parties so as to
efficiently enable location of a missing participant [52]; (b) study participants need to
receive statements of gratitude for their participation from the research staff, who should
thank them for their time and interact with them in a genuine and personal manner [15, 36,
52]; (c) every effort should be made to regularly update participants on the progress of the
research project and to provide consistent feedback on individual progress [15, 36],
including the use of newer technology such as text messaging [53]; (d) participants should
be constantly reminded of the potential real-world impact of the study and the importance of
their participation [7, 10, 36]; and (e) flexibility in research design and eliminating barriers
to participation by accommodating the needs of the older adults, especially those with
limited functional ability, such as providing more accessible locations and time frames for
scheduled meetings, providing adequate breaks between testing sessions and abbreviating
such session so as to prevent exhaustion [10, 12, 15, 36, 52]. In addition, providing roundtrip
transportation to study sites, conducting portions of interviews and observations in natural
home and residential settings, and working with staff and administrators at long-term living
centers where older adults may reside may address logistical concerns and provide
additional support to the older adult participant.

Author Manuscript
Author Manuscript

The literature discussing strategies for retention, specifically in working with older adults is
limited, but Dennis and Neese [54] offer six suggestions to efficiently and respectfully
recruit and retain culturally diverse older adult participants. First, researchers should be
culturally aware and understand the historical abuses of certain populations, such as African
Americans in the name of science. Second, researchers should seek relationships with and
permission of the formal and informal local leadership. Third, researchers should build trust
with participants by making the research process as accessible and inclusive as possible,
spend the time to educate participants, and promptly and openly address any conflicts that
arise. Fourth, researchers should work in partnership with participants, empowering
individuals to work in mutual respect and effort with researchers, not in a situation where the
researcher has more choice or power than the participant. Fifth, researchers and staff should
recognize the vast in-group differences between people who self-identify in a certain cultural
or ethnic group and they should not make assumptions about culture, values, ideas, and
norms. Finally, researchers should constantly be aware of their thoughts and actions and
engage in self-reflection [54].
The findings of this study provide formative data to help move the field forward in
developing sound research designs and retention designs that take into the particular
concerns and considerations that arise when developing recruitment and retention plans with
older adults that buffer against the risk of attrition.
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Figure 1.

Kaplan Meier survival curve for the full sample
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Figure 2.

Kaplan Meier survival curve for the MRI sample
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